Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
74.05
-0.27 (-0.36%)
At close: May 22, 2026, 4:00 PM EDT
72.88
-1.17 (-1.58%)
After-hours: May 22, 2026, 7:06 PM EDT
Spyre Therapeutics Employees
Spyre Therapeutics had 112 employees as of March 31, 2026. The number of employees increased by 39 or 53.42% compared to the same quarter last year.
Employees
112
Change
39
Growth
53.42%
Revenue / Employee
n/a
Profits / Employee
-$1,327,705
Market Cap
6.43B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| Vaxcyte | 507 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 253 |
SYRE News
- 12 days ago - Spyre Therapeutics price target raised to $102 from $86 at Deutsche Bank - TheFly
- 18 days ago - Spyre Therapeutics price target raised to $97 from $64 at Citi - TheFly
- 18 days ago - Spyre Therapeutics price target raised to $107 from $92 at Stifel - TheFly
- 19 days ago - Spyre Therapeutics reports Q1 EPS (74c), consensus (65c) - TheFly
- 19 days ago - Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 days ago - Spyre Therapeutics Quarterly report: Q1 2026 - Filings
- 19 days ago - Spyre Therapeutics Earnings release: Q1 2026 - Filings
- 23 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - GlobeNewsWire